Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

[Reduction of Coercion Measures: All is not Enough].

Reisch T.

Psychiatr Prax. 2019 Oct;46(7):365-368. doi: 10.1055/a-0971-6048. Epub 2019 Oct 7. German. No abstract available.

PMID:
31590194
2.

Assisted Suicide in Switzerland.

Bartsch C, Landolt K, Ristic A, Reisch T, Ajdacic-Gross V.

Dtsch Arztebl Int. 2019 Aug 9;116(33-34):545-552. doi: 10.3238/arztebl.2019.0545.

3.

Suicide by hanging: Results from a national survey in Switzerland and its implications for suicide prevention.

Reisch T, Hartmann C, Hemmer A, Bartsch C.

PLoS One. 2019 Sep 18;14(9):e0220508. doi: 10.1371/journal.pone.0220508. eCollection 2019.

4.

A comprehensive analysis of attempted and fatal suicide cases involving frequently used psychotropic medications.

Pfeifer P, Greusing S, Kupferschmidt H, Bartsch C, Reisch T.

Gen Hosp Psychiatry. 2019 Jul 16. pii: S0163-8343(19)30155-0. doi: 10.1016/j.genhosppsych.2019.07.011. [Epub ahead of print]

PMID:
31327529
5.

Attitudinal variance among patients, next of kin and health care professionals towards the use of containment measures in three psychiatric hospitals in Switzerland.

Hotzy F, Jaeger M, Buehler E, Moetteli S, Klein G, Beeri S, Reisch T.

BMC Psychiatry. 2019 Apr 29;19(1):128. doi: 10.1186/s12888-019-2092-9.

6.

The first 100 patients treated with a new anatomical pre-contoured locking plate for clavicular midshaft fractures.

Reisch T, Camenzind RS, Fuhrer R, Riede U, Helmy N.

BMC Musculoskelet Disord. 2019 Jan 5;20(1):4. doi: 10.1186/s12891-018-2396-9.

7.

Acute Motor Failure of the N. Peroneus Profundus Caused by a Cystic Tibiofibular Joint.

Reisch T, Helmy N, Antoniadis A.

Z Orthop Unfall. 2019 Oct;157(5):562-565. doi: 10.1055/a-0790-8542. Epub 2018 Dec 11. English, German.

PMID:
30537765
8.

Comparing Attitudes to Containment Measures of Patients, Health Care Professionals and Next of Kin.

Reisch T, Beeri S, Klein G, Meier P, Pfeifer P, Buehler E, Hotzy F, Jaeger M.

Front Psychiatry. 2018 Oct 26;9:529. doi: 10.3389/fpsyt.2018.00529. eCollection 2018.

9.

Suicide by firearm in Switzerland: who uses the army weapon? Results from the national survey between 2000 and 2010.

Thoeni N, Reisch T, Hemmer A, Bartsch C.

Swiss Med Wkly. 2018 Sep 23;148:w14646. doi: 10.4414/smw.2018.14646. eCollection 2018 Sep 10.

10.

Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.

Schnell G, Krishnan P, Tripathi R, Beyer J, Reisch T, Irvin M, Dekhtyar T, Lu L, Ng TI, Xie W, Pilot-Matias T, Collins C.

PLoS One. 2018 Oct 4;13(10):e0205186. doi: 10.1371/journal.pone.0205186. eCollection 2018.

11.

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.

Ng TI, Pilot-Matias T, Tripathi R, Schnell G, Krishnan P, Reisch T, Beyer J, Dekhtyar T, Irvin M, Lu L, Asatryan A, Campbell A, Yao B, Lovell S, Mensa F, Lawitz EJ, Kort J, Collins C.

Viruses. 2018 Aug 28;10(9). pii: E462. doi: 10.3390/v10090462.

12.

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials.

Krishnan P, Pilot-Matias T, Schnell G, Tripathi R, Ng TI, Reisch T, Beyer J, Dekhtyar T, Irvin M, Xie W, Larsen L, Mensa FJ, Collins C.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01249-18. doi: 10.1128/AAC.01249-18. Print 2018 Oct.

13.

Reasons for living and dying in suicide attempters: a two-year prospective study.

Brüdern J, Stähli A, Gysin-Maillart A, Michel K, Reisch T, Jobes DA, Brodbeck J.

BMC Psychiatry. 2018 Jul 20;18(1):234. doi: 10.1186/s12888-018-1814-8.

14.

[Suicides of Psychiatric Inpatients - A Systematic Recording in Switzerland of the Years 2000 to 2010].

Ruff F, Hemmer A, Bartsch C, Glasow N, Reisch T.

Psychiatr Prax. 2018 Sep;45(6):307-313. doi: 10.1055/s-0043-120888. Epub 2018 Apr 17. German.

PMID:
29665611
15.

Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530).

Wagner R, Randolph JT, Patel SV, Nelson L, Matulenko MA, Keddy R, Pratt JK, Liu D, Krueger AC, Donner PL, Hutchinson DK, Flentge C, Betebenner D, Rockway T, Maring CJ, Ng TI, Krishnan P, Pilot-Matias T, Collins C, Panchal N, Reisch T, Dekhtyar T, Mondal R, Stolarik DF, Gao Y, Gao W, Beno DA, Kati WM.

J Med Chem. 2018 May 10;61(9):4052-4066. doi: 10.1021/acs.jmedchem.8b00082. Epub 2018 Apr 23.

PMID:
29653491
16.

Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir.

Schnell G, Tripathi R, Beyer J, Reisch T, Krishnan P, Dekhtyar T, Irvin M, Hall C, Yu Y, Mobashery N, Redman R, Pilot-Matias T, Collins C.

J Viral Hepat. 2018 Sep;25(9):1078-1088. doi: 10.1111/jvh.12906. Epub 2018 May 8.

PMID:
29624809
17.

Large tunable valley splitting in edge-free graphene quantum dots on boron nitride.

Freitag NM, Reisch T, Chizhova LA, Nemes-Incze P, Holl C, Woods CR, Gorbachev RV, Cao Y, Geim AK, Novoselov KS, Burgdörfer J, Libisch F, Morgenstern M.

Nat Nanotechnol. 2018 May;13(5):392-397. doi: 10.1038/s41565-018-0080-8. Epub 2018 Mar 19.

PMID:
29556008
18.

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.

Krishnan P, Schnell G, Tripathi R, Beyer J, Reisch T, Dekhtyar T, Irvin M, Xie W, Fu B, Burroughs M, Redman R, Kumada H, Chayama K, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02217-17. doi: 10.1128/AAC.02217-17. Print 2018 Feb.

19.

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir.

Ng TI, Tripathi R, Reisch T, Lu L, Middleton T, Hopkins TA, Pithawalla R, Irvin M, Dekhtyar T, Krishnan P, Schnell G, Beyer J, McDaniel KF, Ma J, Wang G, Jiang LJ, Or YS, Kempf D, Pilot-Matias T, Collins C.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01620-17. doi: 10.1128/AAC.01620-17. Print 2018 Jan.

20.

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir.

Schnell G, Tripathi R, Krishnan P, Beyer J, Reisch T, Irvin M, Dekhtyar T, Setze C, Rodrigues L Jr, Alves K, Burroughs M, Redman R, Chayama K, Kumada H, Collins C, Pilot-Matias T.

J Med Virol. 2018 Jan;90(1):109-119. doi: 10.1002/jmv.24923. Epub 2017 Sep 22.

21.

Acute and chronic alcohol use correlated with methods of suicide in a Swiss national sample.

Pfeifer P, Bartsch C, Hemmer A, Reisch T.

Drug Alcohol Depend. 2017 Sep 1;178:75-79. doi: 10.1016/j.drugalcdep.2017.05.009. Epub 2017 Jun 16.

PMID:
28645062
22.

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.

Ng TI, Krishnan P, Pilot-Matias T, Kati W, Schnell G, Beyer J, Reisch T, Lu L, Dekhtyar T, Irvin M, Tripathi R, Maring C, Randolph JT, Wagner R, Collins C.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02558-16. doi: 10.1128/AAC.02558-16. Print 2017 May.

23.

Comparing Different Suicide Prevention Measures at Bridges and Buildings: Lessons We Have Learned from a National Survey in Switzerland.

Hemmer A, Meier P, Reisch T.

PLoS One. 2017 Jan 6;12(1):e0169625. doi: 10.1371/journal.pone.0169625. eCollection 2017.

24.

Discovery of fluorobenzimidazole HCV NS5A inhibitors.

Randolph JT, Flentge CA, Donner P, Rockway TW, Patel SV, Nelson L, Hutchinson DK, Mondal R, Mistry N, Reisch T, Dekhtyar T, Krishnan P, Pilot-Matias T, Stolarik DF, Beno DWA, Wagner R, Maring C, Kati WM.

Bioorg Med Chem Lett. 2016 Nov 15;26(22):5462-5467. doi: 10.1016/j.bmcl.2016.10.030. Epub 2016 Oct 13.

PMID:
27780635
25.

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir.

Krishnan P, Schnell G, Tripathi R, Beyer J, Reisch T, Zhang X, Setze C, Rodrigues L Jr, Burroughs M, Redman R, Chayama K, Kumada H, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1106-13. doi: 10.1128/AAC.02606-15. Print 2016 Feb.

26.

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.

Schnell G, Tripathi R, Beyer J, Reisch T, Krishnan P, Lu L, Dekhtyar T, Hall C, Vilchez RA, Pilot-Matias T, Collins C.

Antimicrob Agents Chemother. 2015 Nov;59(11):6807-15. doi: 10.1128/AAC.01229-15. Epub 2015 Aug 17.

27.

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir.

Krishnan P, Tripathi R, Schnell G, Reisch T, Beyer J, Irvin M, Xie W, Larsen L, Cohen D, Podsadecki T, Pilot-Matias T, Collins C.

Antimicrob Agents Chemother. 2015 Sep;59(9):5445-54. doi: 10.1128/AAC.00998-15. Epub 2015 Jun 22.

28.

Road Traffic Suicide in Switzerland.

Gauthier S, Reisch T, Ajdacic-Gross V, Bartsch C.

Traffic Inj Prev. 2015;16(8):768-72. doi: 10.1080/15389588.2015.1021419. Epub 2015 Mar 20.

PMID:
25793638
29.

Swiss Prison Suicides Between 2000 and 2010.

Gauthier S, Reisch T, Bartsch C.

Crisis. 2015 Jun;36(2):110-116. Epub 2015 Feb 23.

PMID:
25708254
30.

In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitor.

Kati W, Koev G, Irvin M, Beyer J, Liu Y, Krishnan P, Reisch T, Mondal R, Wagner R, Molla A, Maring C, Collins C.

Antimicrob Agents Chemother. 2015 Mar;59(3):1505-11. doi: 10.1128/AAC.04619-14. Epub 2014 Dec 22.

31.

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A.

Krishnan P, Beyer J, Mistry N, Koev G, Reisch T, DeGoey D, Kati W, Campbell A, Williams L, Xie W, Setze C, Molla A, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2015 Feb;59(2):979-87. doi: 10.1128/AAC.04226-14. Epub 2014 Dec 1.

32.

In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.

Pilot-Matias T, Tripathi R, Cohen D, Gaultier I, Dekhtyar T, Lu L, Reisch T, Irvin M, Hopkins T, Pithawalla R, Middleton T, Ng T, McDaniel K, Or YS, Menon R, Kempf D, Molla A, Collins C.

Antimicrob Agents Chemother. 2015 Feb;59(2):988-97. doi: 10.1128/AAC.04227-14. Epub 2014 Dec 1.

33.

Suicide tourism: a pilot study on the Swiss phenomenon.

Gauthier S, Mausbach J, Reisch T, Bartsch C.

J Med Ethics. 2015 Aug;41(8):611-7. doi: 10.1136/medethics-2014-102091. Epub 2014 Aug 20.

PMID:
25142806
34.

Self-burning - a rare suicide method in Switzerland and other industrialised nations - a review.

Gauthier S, Reisch T, Bartsch Ch.

Burns. 2014 Dec;40(8):1720-6. doi: 10.1016/j.burns.2014.02.007. Epub 2014 Apr 29. Review.

PMID:
24794228
35.

Suicide assisted by right-to-die associations: a population based cohort study.

Steck N, Junker C, Maessen M, Reisch T, Zwahlen M, Egger M; Swiss National Cohort.

Int J Epidemiol. 2014 Apr;43(2):614-22. doi: 10.1093/ije/dyu010. Epub 2014 Feb 18.

PMID:
24550250
36.

Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A.

DeGoey DA, Randolph JT, Liu D, Pratt J, Hutchins C, Donner P, Krueger AC, Matulenko M, Patel S, Motter CE, Nelson L, Keddy R, Tufano M, Caspi DD, Krishnan P, Mistry N, Koev G, Reisch TJ, Mondal R, Pilot-Matias T, Gao Y, Beno DW, Maring CJ, Molla A, Dumas E, Campbell A, Williams L, Collins C, Wagner R, Kati WM.

J Med Chem. 2014 Mar 13;57(5):2047-57. doi: 10.1021/jm401398x. Epub 2014 Jan 15.

PMID:
24400777
37.

Gender differences in methods of suicide attempts and prevalence of previous suicide attempts.

Kupferschmid S, Gysin-Maillart A, Bühler SK, Steffen T, Michel K, Schimmelmann BG, Reisch T.

Z Kinder Jugendpsychiatr Psychother. 2013 Nov;41(6):401-5. doi: 10.1024/1422-4917/a000256.

38.

Euthanasia and assisted suicide in selected European countries and US states: systematic literature review.

Steck N, Egger M, Maessen M, Reisch T, Zwahlen M.

Med Care. 2013 Oct;51(10):938-44. doi: 10.1097/MLR.0b013e3182a0f427. Review.

PMID:
23929402
39.

Change in suicide rates in Switzerland before and after firearm restriction resulting from the 2003 “Army XXI” reform.

Reisch T, Steffen T, Habenstein A, Tschacher W.

Am J Psychiatry. 2013 Sep;170(9):977-84. doi: 10.1176/appi.ajp.2013.12091256.

PMID:
23897090
40.

Brain regions associated with psychological pain.

Habenstein A, Reisch T, Michel K.

Brain Imaging Behav. 2013 Sep;7(3):243-4. doi: 10.1007/s11682-013-9229-0. No abstract available.

41.

Serious suicidal behaviors: socio-demographic and clinical features in a multinational, multicenter sample.

Carli V, Mandelli L, Zaninotto L, Iosue M, Hadlaczky G, Wasserman D, Hegerl U, Värnik A, Reisch T, Pfuhlmann B, Maloney J, Schmidtke A, Serretti A, Sarchiapone M.

Nord J Psychiatry. 2014 Jan;68(1):44-52. doi: 10.3109/08039488.2013.767934. Epub 2013 Feb 19.

PMID:
23421730
42.

Chances and limits of method restriction: a detailed analysis of suicide methods in Switzerland.

Habenstein A, Steffen T, Bartsch C, Michaud K, Reisch T.

Arch Suicide Res. 2013;17(1):75-87. doi: 10.1080/13811118.2013.748418.

PMID:
23387405
43.

[Where can suicide prevention be applied? Proposal of a 6-phase model for suicidal crises].

Reisch T.

Psychiatr Prax. 2012 Aug;39(6):257-8. doi: 10.1055/s-0032-1305205. Epub 2012 Aug 27. German. No abstract available.

PMID:
22926787
44.

Suicide in breast cancer patients: an individual-centered approach provides insight beyond epidemiology.

Güth U, Myrick ME, Reisch T, Bosshard G, Schmid SM.

Acta Oncol. 2011 Oct;50(7):1037-44. doi: 10.3109/0284186X.2011.602112. Epub 2011 Aug 23.

PMID:
21861596
45.

Drug suicide: a sex-equal cause of death in 16 European countries.

Värnik A, Sisask M, Värnik P, Wu J, Kõlves K, Arensman E, Maxwell M, Reisch T, Gusmão R, van Audenhove C, Scheerder G, van der Feltz-Cornelis CM, Coffey C, Kopp M, Szekely A, Roskar S, Hegerl U.

BMC Public Health. 2011 Jan 29;11(1):61. doi: 10.1186/1471-2458-11-61.

46.

An fMRI study on mental pain and suicidal behavior.

Reisch T, Seifritz E, Esposito F, Wiest R, Valach L, Michel K.

J Affect Disord. 2010 Oct;126(1-2):321-5. doi: 10.1016/j.jad.2010.03.005.

PMID:
20434779
47.

Suicide attempters' memory traces of exposure to suicidal behavior: a qualitative pilot study.

Ventrice D, Valach L, Reisch T, Michel K.

Crisis. 2010;31(2):93-9. doi: 10.1027/0227-5910/a000013.

PMID:
20418215
48.

Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.

Randolph JT, Flentge CA, Huang PP, Hutchinson DK, Klein LL, Lim HB, Mondal R, Reisch T, Montgomery DA, Jiang WW, Masse SV, Hernandez LE, Henry RF, Liu Y, Koev G, Kati WM, Stewart KD, Beno DW, Molla A, Kempf DJ.

J Med Chem. 2009 May 28;52(10):3174-83. doi: 10.1021/jm801485z.

PMID:
19402666
49.

Suicide by jumping from bridges and other heights: social and diagnostic factors.

Reisch T, Schuster U, Michel K.

Psychiatry Res. 2008 Oct 30;161(1):97-104. doi: 10.1016/j.psychres.2007.06.028. Epub 2008 Sep 16.

PMID:
18799221
50.

Gender issues in suicide rates, trends and methods among youths aged 15-24 in 15 European countries.

Värnik A, Kõlves K, Allik J, Arensman E, Aromaa E, van Audenhove C, Bouleau JH, van der Feltz-Cornelis CM, Giupponi G, Gusmão R, Kopp M, Marusic A, Maxwell M, Oskarsson H, Palmer A, Pull C, Realo A, Reisch T, Schmidtke A, Pérez Sola V, Wittenburg L, Hegerl U.

J Affect Disord. 2009 Mar;113(3):216-26. doi: 10.1016/j.jad.2008.06.004. Epub 2008 Jul 14.

PMID:
18625519

Supplemental Content

Loading ...
Support Center